Actively Recruiting
Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
Led by West Kazakhstan Marat Ospanov Medical University · Updated on 2026-04-06
310
Participants Needed
1
Research Sites
73 weeks
Total Duration
On this page
Sponsors
W
West Kazakhstan Marat Ospanov Medical University
Lead Sponsor
U
Universitatea de Stat de Medicina si Farmacie Nicolae Testemiţanu
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to better understand how the pancreas works in adults with type 2 diabetes. The study focuses on both hormone production (endocrine function) and digestive function (exocrine function) of the pancreas. The main questions it aims to answer are: * Can problems with the pancreas help identify a different type of diabetes called pancreatogenic diabetes? * How are blood markers and pancreas structure related to pancreatic function? Participants will: * Have blood tests to measure glucose, insulin, and other markers * Provide a stool sample to assess digestive function * Undergo an ultrasound examination of the pancreas * Answer questions about digestive symptoms The study will take place during a single visit in outpatient clinics.
CONDITIONS
Official Title
Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients of Kazakh nationality aged 18 to 74 years
- Diagnosis of type 2 diabetes established according to ADA criteria and documented in medical records
- Disease duration of 5 years or less
- No ketoacidosis episodes within the last 6 months
You will not qualify if you...
- Positive anti-glutamic acid decarboxylase antibodies (anti-GAD65)
- Acute or chronic infections affecting metabolic status within the previous 4 weeks
- Any history of malignant neoplasms
- Pregnancy or lactation
- Previously diagnosed type 1 diabetes mellitus or other specific types of diabetes
- Severe decompensated chronic diseases
- Conditions associated with systemic fibrosis (e.g., liver cirrhosis or autoimmune diseases)
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Outpatient clinics of Aktobe region, West Kazakhstan Marat Ospanov Medical University
Aktobe, Aktobe, Kazakhstan, 030019
Actively Recruiting
Research Team
M
Mengtay S Makashova
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here